Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Short Interest Update

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) was the recipient of a significant growth in short interest in April. As of April 15th, there was short interest totaling 39,684 shares, a growth of 20.5% from the March 31st total of 32,930 shares. Based on an average daily volume of 15,042 shares, the days-to-cover ratio is presently 2.6 days.

Conduit Pharmaceuticals Stock Down 16.6%

Shares of Conduit Pharmaceuticals stock traded down $0.00 during trading on Friday, hitting $0.01. 900 shares of the stock traded hands, compared to its average volume of 21,772. The company has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01. Conduit Pharmaceuticals has a twelve month low of $0.01 and a twelve month high of $0.02.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.